Ardelius Saye Boan, NP
Nurse Practitioner · Fairfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Northbay Physicians Surgery Center, LLC · Northbay Health Medical Foundation
Hospitals listed: Northbay Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ardelius Saye Boan’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Northbay Medical CenterFairfield, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Northbay Healthcare, which runs 2 hospitalsPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.6 (11 to 18.8) · 166 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Northbay Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.6 (11 to 18.8) · 166 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.08 (0.1 to 2.06) · 1,001 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.7 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.67 (132.84 to 228.51) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 180 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 338 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 552 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 238 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 2,034 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,385 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.02 (1.87 to 6.16) · 1,179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.02 (0.51 to 3.54) · 1,156 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.55 (4.71 to 20.39) · 284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.99 to 9.92) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1) · 4,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 25 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.663 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.985 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.763 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.923 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 420 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.7 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 439 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25 · 627 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 560 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.7 to 7.9) · 166 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 210 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.5 to 19) · 196 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 250 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,123 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$31,983
Medicare paid this office $31,983 for 166 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 48 | $7,714 | $138 |
| Return visit (30+ min) | 64 | $7,489 | $99 |
| New patient visit (60+ min) | 40 | $6,666 | $167 |
| New patient visit (45+ min) | 44 | $5,248 | $119 |
| Short return visit (20+ min) | 43 | $2,948 | $64 |
See all 6 services
| Long return visit (40+ min) | 48 | $7,714 | $138 |
| Return visit (30+ min) | 64 | $7,489 | $99 |
| New patient visit (60+ min) | 40 | $6,666 | $167 |
| New patient visit (45+ min) | 44 | $5,248 | $119 |
| Short return visit (20+ min) | 43 | $2,948 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,110 | $93 |
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 21% · Women 61% · Also on Medicaid 42% · Health risk score 1.42. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 31% · Depression 30% · Stroke 30% · Chronic kidney disease 25% · Coronary heart disease 23% · Heart failure 17% · Atrial fibrillation 17% · Dementia 17% · Cancer 16% · COPD 14%.
The office billed $111,296, Medicare allowed $40,836 and paid $31,983; for 289 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 166 | 289 | 75 | 1.42 | $111,296 | $31,983 |
| 2020 | 13 | 14 | 72 | 2.16 | $5,589 | $1,413 |
| 2019 | 132 | 243 | 72 | 3.24 | $41,179 | $12,812 |
| 2018 | 145 | 831 | 72 | 2.97 | $117,568 | $41,532 |
| 2017 | 175 | 1,481 | 72 | 3.59 | $185,001 | $66,629 |
| 2016 | 118 | 836 | 73 | 3.27 | $108,550 | $39,893 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 4 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 84 | $6,242 | $43 |
| Critical care, first 30-74 minutes | 18 | $2,477 | $138 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 34 | $1,968 | $48 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 12 | $459 | $29 |
2018: 5 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 107 | $23,074 | $44 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 90 | $12,375 | $59 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 24 | $1,048 | $28 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,026 | $68 |
| Nursing facility discharge management, more than 30 minutes | 12 | $833 | $69 |
2017: 5 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 154 | $44,687 | $44 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 137 | $14,665 | $58 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 56 | $3,698 | $28 |
| Nursing facility discharge day management, 30 minutes or less | 46 | $2,250 | $46 |
| Nursing facility discharge management, more than 30 minutes | 17 | $1,175 | $69 |
2016: 3 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 109 | $26,710 | $45 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 85 | $11,905 | $59 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 19 | $697 | $29 |
Medicaid work
$3,885 in 2024
Medicaid paid $3,885 for 106 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 44 | $1,238 |
| New patient visit (60+ min) | 16 | $1,075 |
| New patient visit (45+ min) | 19 | $827 |
| Long return visit (40+ min) | 14 | $458 |
| Short return visit (20+ min) | 13 | $288 |
| 2024 | 106 | 5 | 19 | $3,885 |
| 2022 | 14 | 1 | 14 | $143 |
| 2019 | 108 | 2 | 22 | $3,059 |
| 2018 | 668 | 2 | 36 | $14,422 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 14 | $143 |
2019
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 93 | $2,222 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 15 | $837 |
2018
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 546 | $11,278 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 122 | $3,144 |
Drugs they prescribed that Part D paid
$20,174
Pharmacies billed $20,174 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 332) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
325 generic and fewer than 11 brand-name prescriptions · $20,174 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa | 49 | $1,541 | $31 |
| Levetiracetam | 32 | $873 | $27 |
| Valproic Acid | 11 | $764 | $69 |
| Memantine | 15 | $493 | $33 |
| Celecoxib | 15 | $372 | $25 |
See all 11 drugs
| Carbidopa-Levodopa | 49 | $1,541 | $31 |
| Levetiracetam | 32 | $873 | $27 |
| Valproic Acid | 11 | $764 | $69 |
| Memantine | 15 | $493 | $33 |
| Celecoxib | 15 | $372 | $25 |
| Gabapentin | 23 | $306 | $13 |
| Donepezil | 35 | $217 | $6 |
| Doxepin | 11 | $208 | $19 |
| Lamotrigine | 12 | $141 | $12 |
| Primidone | 11 | $104 | $9 |
| Quetiapine | 15 | $68 | $5 |
Year by year
| 2024 | 332 | 111 | 0% (0) | None | $20,174 |
| 2023 | 381 | 87 | 0% (0) | 13% | $127,875 |
| 2022 | 631 | 131 | 0% (0) | None | $239,260 |
| 2021 | 511 | 110 | 0% (0) | None | $134,768 |
| 2020 | 166 | 58 | None | 8% | $20,743 |
| 2019 | 794 | 66 | 2% (17) | None | $46,505 |
| 2018 | 1,905 | 139 | 3% (56) | None | $154,833 |
| 2017 | 2,313 | 170 | 5% (118) | None | $215,263 |
| 2016 | 611 | 85 | 13% (82) | None | $28,390 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Lamictal | None | 11 | $44,420 | $4,038 |
| Aimovig | Migraine | 17 | $13,618 | $801 |
| Levetiracetam | None | 46 | $4,935 | $107 |
| Entacapone | None | 11 | $3,190 | $290 |
| Carbidopa-Levodopa | None | 69 | $2,792 | $40 |
| Zonisamide | None | 14 | $1,435 | $103 |
| Lamotrigine | None | 16 | $1,024 | $64 |
| Topiramate | None | 20 | $809 | $40 |
| Gabapentin | None | 19 | $774 | $41 |
| Mycophenolate Mofetil | None | 12 | $647 | $54 |
| Baclofen | None | 13 | $277 | $21 |
| Atorvastatin | None | 15 | $128 | $9 |
2022: 19 drugs
| Lamictal | None | 12 | $46,560 | $3,880 |
| Vimpat | None | 14 | $22,377 | $1,598 |
| Emgality | Migraine | 12 | $10,249 | $854 |
| Neupro | None | 11 | $9,051 | $823 |
| Entacapone | None | 25 | $8,003 | $320 |
| Levetiracetam | None | 56 | $4,568 | $82 |
| Carbidopa-Levodopa | None | 71 | $3,545 | $50 |
| Topiramate | None | 35 | $2,271 | $65 |
| Dilantin | None | 11 | $2,103 | $191 |
| Pyridostigmine | None | 15 | $1,534 | $102 |
| Gabapentin | None | 34 | $1,123 | $33 |
| Zonisamide | None | 40 | $1,103 | $28 |
| Baclofen | None | 27 | $789 | $29 |
| Divalproex | None | 13 | $730 | $56 |
| Pregabalin | None | 11 | $416 | $38 |
| Propranolol | None | 15 | $364 | $24 |
| Lamotrigine | None | 16 | $335 | $21 |
| Donepezil | None | 14 | $231 | $16 |
| Clonazepam | None | 14 | $68 | $5 |
2021: 18 drugs
| Vimpat | 18 | $18,916 | $1,051 |
| Dalfampridine Er | 12 | $6,276 | $523 |
| Levetiracetam | 27 | $3,420 | $127 |
| Dilantin | 12 | $2,165 | $180 |
| Carbidopa-Levodopa | 34 | $1,939 | $57 |
| Entacapone | 13 | $1,209 | $93 |
| Zonisamide | 32 | $1,072 | $33 |
| Mycophenolate Mofetil | 11 | $933 | $85 |
| Pyridostigmine | 13 | $892 | $69 |
| Topiramate | 30 | $886 | $30 |
| Lamotrigine | 32 | $517 | $16 |
| Gabapentin | 37 | $489 | $13 |
| Tizanidine | 11 | $291 | $26 |
| Prednisone | 12 | $165 | $14 |
| Nortriptyline | 14 | $147 | $10 |
| Sulfamethoxazole-Trimethoprim | 16 | $119 | $7 |
| Sumatriptan | 18 | $117 | $6 |
| Clonazepam | 13 | $56 | $4 |
2020: 2 drugs
| Gabapentin | 14 | $180 | $13 |
| Sumatriptan | 14 | $110 | $8 |
2019: 25 drugs
| Myrbetriq | 42 | $8,141 | $194 |
| Linzess | 15 | $6,659 | $444 |
| Eliquis | 11 | $3,417 | $311 |
| Memantine Hcl Er | 13 | $3,193 | $246 |
| Humalog Kwikpen U-100 | 20 | $2,306 | $115 |
| Duloxetine | 15 | $1,797 | $120 |
| Mirtazapine | 36 | $968 | $27 |
| Prazosin | 12 | $915 | $76 |
| Midodrine | 11 | $914 | $83 |
| Atorvastatin | 40 | $780 | $19 |
| Tamsulosin | 16 | $565 | $35 |
| Gabapentin | 29 | $542 | $19 |
| Donepezil | 23 | $421 | $18 |
| Furosemide | 43 | $351 | $8 |
| Metoprolol | 37 | $285 | $8 |
| Propranolol | 17 | $269 | $16 |
| Amlodipine Besylate | 25 | $240 | $10 |
| Omeprazole | 19 | $201 | $11 |
| Levothyroxine | 17 | $199 | $12 |
| Klor-Con 10 | 23 | $195 | $8 |
| Clonidine | 14 | $186 | $13 |
| Metformin | 25 | $183 | $7 |
| Risperidone | 12 | $181 | $15 |
| Lithium Carbonate | 12 | $171 | $14 |
| Lisinopril | 19 | $150 | $8 |
2018: 66 drugs
| Linzess | 21 | $8,470 | $403 |
| Exelon | 11 | $7,727 | $702 |
| Eliquis | 15 | $4,894 | $326 |
| Myrbetriq | 23 | $4,785 | $208 |
| Lantus Solostar | 25 | $4,368 | $175 |
| Xarelto | 17 | $4,090 | $241 |
| Vesicare | 22 | $4,000 | $182 |
| Janumet | 16 | $3,404 | $213 |
| Lyrica | 15 | $2,809 | $187 |
| Levemir Flextouch | 17 | $2,626 | $154 |
| Humalog Kwikpen U-100 | 21 | $2,424 | $115 |
| Namenda Xr | 11 | $2,392 | $217 |
| Olopatadine | 18 | $2,254 | $125 |
| Memantine Hcl Er | 16 | $2,080 | $130 |
| Midodrine | 18 | $2,046 | $114 |
| Humalog | 20 | $2,006 | $100 |
| Prazosin | 18 | $1,818 | $101 |
| Mirtazapine | 59 | $1,751 | $30 |
| Omega-3 Acid Ethyl Esters | 11 | $1,536 | $140 |
| Dexilant | 11 | $1,511 | $137 |
| Methenamine Hippurate | 14 | $1,365 | $98 |
| Duloxetine | 25 | $1,344 | $54 |
| Levetiracetam | 26 | $1,222 | $47 |
| Potassium Chloride | 31 | $1,206 | $39 |
| Quetiapine | 29 | $764 | $26 |
| Oxybutynin Chloride Er | 11 | $757 | $69 |
| Venlafaxine Hcl Er | 12 | $696 | $58 |
| Gabapentin | 39 | $695 | $18 |
| Baclofen | 11 | $663 | $60 |
| Tamsulosin | 19 | $619 | $33 |
| Warfarin | 40 | $592 | $15 |
| Furosemide | 86 | $574 | $7 |
| Atorvastatin | 34 | $533 | $16 |
| Levothyroxine | 34 | $501 | $15 |
| Hydralazine | 15 | $475 | $32 |
| Butalbital-Acetaminophen-Caffe | 14 | $458 | $33 |
| Fluticasone Propionate | 20 | $436 | $22 |
| Calcitriol | 14 | $420 | $30 |
| Amlodipine Besylate | 40 | $419 | $10 |
| Buspirone | 19 | $413 | $22 |
| Meclizine | 19 | $354 | $19 |
| Chlorthalidone | 13 | $353 | $27 |
| Metformin | 38 | $353 | $9 |
| Ondansetron | 13 | $331 | $25 |
| Oxycodone-Acetaminophen | 15 | $324 | $22 |
| Amitriptyline | 17 | $303 | $18 |
| Klor-Con 10 | 31 | $284 | $9 |
| Clonidine | 21 | $264 | $13 |
| Clopidogrel | 18 | $263 | $15 |
| Lisinopril | 41 | $251 | $6 |
| Montelukast | 11 | $245 | $22 |
| Carvedilol | 18 | $243 | $14 |
| Pantoprazole | 21 | $231 | $11 |
| Metoprolol | 28 | $229 | $8 |
| Metoprolol | 17 | $228 | $13 |
| Losartan-Hydrochlorothiazide | 11 | $212 | $19 |
| Donepezil | 20 | $210 | $11 |
| Pravastatin | 13 | $179 | $14 |
| Pramipexole Dihydrochloride | 13 | $157 | $12 |
| Lovastatin | 11 | $133 | $12 |
| Tramadol | 22 | $132 | $6 |
| Ranitidine | 11 | $117 | $11 |
| Prednisone | 16 | $110 | $7 |
| Hydrocodone-Acetaminophen | 14 | $100 | $7 |
| Trazodone | 11 | $86 | $8 |
| Omeprazole | 14 | $52 | $4 |
2017: 63 drugs
| Copaxone | 19 | $29,325 | $1,543 |
| Latuda | 21 | $11,559 | $550 |
| Lantus | 34 | $9,452 | $278 |
| Namenda Xr | 36 | $7,267 | $202 |
| Levemir | 25 | $7,235 | $289 |
| Linzess | 19 | $7,199 | $379 |
| Janumet | 29 | $6,011 | $207 |
| Enoxaparin | 22 | $5,440 | $247 |
| Eliquis | 22 | $4,178 | $190 |
| Novolog | 13 | $3,705 | $285 |
| Midodrine | 33 | $3,381 | $102 |
| Xarelto | 24 | $3,233 | $135 |
| Potassium Chloride | 61 | $2,627 | $43 |
| Dexilant | 17 | $2,293 | $135 |
| Albuterol Sulfate | 15 | $1,969 | $131 |
| Mirtazapine | 65 | $1,952 | $30 |
| Olopatadine | 12 | $1,659 | $138 |
| Divalproex | 12 | $1,640 | $137 |
| Methenamine Hippurate | 17 | $1,588 | $93 |
| Oxybutynin Chloride Er | 23 | $1,428 | $62 |
| Polyethylene Glycol 3350 | 21 | $1,343 | $64 |
| Fentanyl | 11 | $1,267 | $115 |
| Omega-3 Acid Ethyl Esters | 13 | $1,091 | $84 |
| Calcitriol | 29 | $962 | $33 |
| Gabapentin | 53 | $882 | $17 |
| Prazosin | 11 | $813 | $74 |
| Hydralazine | 30 | $668 | $22 |
| Warfarin | 57 | $656 | $12 |
| Levothyroxine | 44 | $617 | $14 |
| Atorvastatin | 46 | $611 | $13 |
| Metformin | 52 | $526 | $10 |
| Kionex | 12 | $521 | $43 |
| Furosemide | 66 | $487 | $7 |
| Trazodone | 41 | $483 | $12 |
| Fluticasone Propionate | 20 | $466 | $23 |
| Oxycodone | 23 | $465 | $20 |
| Hydrocodone-Acetaminophen | 34 | $459 | $13 |
| Levetiracetam | 20 | $457 | $23 |
| Metoprolol | 48 | $453 | $9 |
| Tamsulosin | 19 | $438 | $23 |
| Gemfibrozil | 13 | $368 | $28 |
| Finasteride | 22 | $345 | $16 |
| Amlodipine Besylate | 39 | $338 | $9 |
| Prednisone | 33 | $328 | $10 |
| Lorazepam | 34 | $321 | $9 |
| Oxycodone-Acetaminophen | 20 | $305 | $15 |
| Pantoprazole | 15 | $305 | $20 |
| Baclofen | 13 | $246 | $19 |
| Donepezil | 16 | $234 | $15 |
| Omeprazole | 27 | $233 | $9 |
| Ipratropium-Albuterol | 12 | $217 | $18 |
| Lisinopril | 28 | $199 | $7 |
| Olanzapine | 15 | $182 | $12 |
| Clopidogrel | 14 | $180 | $13 |
| Sulfamethoxazole-Trimethoprim | 13 | $164 | $13 |
| Alprazolam | 21 | $164 | $8 |
| Lithium Carbonate | 20 | $162 | $8 |
| Pramipexole Dihydrochloride | 15 | $155 | $10 |
| Azithromycin | 12 | $150 | $12 |
| Tramadol | 17 | $123 | $7 |
| Citalopram Hbr | 13 | $110 | $8 |
| Meloxicam | 15 | $100 | $7 |
| Atenolol | 11 | $43 | $4 |
2016: 13 drugs
| Lantus | 13 | $3,539 | $272 |
| Potassium Chloride | 11 | $510 | $46 |
| Warfarin | 29 | $379 | $13 |
| Oxycodone-Acetaminophen | 11 | $334 | $30 |
| Furosemide | 39 | $307 | $8 |
| Lorazepam | 27 | $286 | $11 |
| Oxycodone | 18 | $272 | $15 |
| Hydrocodone-Acetaminophen | 16 | $184 | $12 |
| Tramadol | 24 | $172 | $7 |
| Metformin | 19 | $164 | $9 |
| Atorvastatin | 12 | $146 | $12 |
| Alprazolam | 16 | $117 | $7 |
| Metoprolol | 13 | $110 | $8 |
Money from drug and device companies
$992 in 2025
| 2025 | 9 | 50 | None | $992 |
| 2024 | 16 | 48 | None | $1,107 |
| 2021 | 3 | 3 | None | $62 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $446 | 19 payments
|
| Neurocrine BioSciences | Ingrezza | $197 | 11 payments
|
| Pfizer | Nurtec Odt | $140 | 10 payments
|
| Lilly USA | Kisunla | $62 | 3 payments
|
| Jazz Pharmaceuticals | Xywav | $53 | 2 payments
|
| Genentech USA | Ocrevus Zunovo | $38 | 2 payments
|
See all 50 published payments
| Abbvie | Meals · 2025-12-30 | Qulipta | $16 |
| Neurocrine BioSciences | Meals · 2025-11-20 | Ingrezza | $9 |
| Amneal Pharmaceuticals | Meals · 2025-11-19 | Crexont | $19 |
| Neurocrine BioSciences | Meals · 2025-11-13 | Ingrezza | $16 |
| Pfizer | Meals · 2025-11-12 | Nurtec Odt | $22 |
| Pfizer | Meals · 2025-10-27 | Nurtec Odt | $9 |
| Abbvie | Meals · 2025-10-24 | Qulipta | $17 |
| Ucb | Meals · 2025-10-17 | Fintepla | $19 |
| Neurocrine BioSciences | Meals · 2025-10-01 | Ingrezza | $39 |
| Abbvie | Meals · 2025-09-24 | Qulipta | $29 |
| Pfizer | Meals · 2025-09-24 | Nurtec Odt | $21 |
| Neurocrine BioSciences | Meals · 2025-09-20 | Ingrezza | $37 |
| Lilly USA | Meals · 2025-09-13 | Kisunla | $22 |
| Pfizer | Meals · 2025-09-12 | Nurtec Odt | $7 |
| Teva Pharmaceuticals USA | Meals · 2025-09-08 | Austedo Xr | $18 |
| Neurocrine BioSciences | Meals · 2025-09-05 | Ingrezza | $15 |
| Neurocrine BioSciences | Meals · 2025-08-29 | Ingrezza | $18 |
| Pfizer | Meals · 2025-08-20 | Nurtec Odt | $27 |
| Abbvie | Meals · 2025-08-15 | Qulipta | $29 |
| Genentech USA | Meals · 2025-08-11 | Ocrevus Zunovo | $17 |
| Abbvie | Meals · 2025-08-06 | Qulipta | $14 |
| Lilly USA | Meals · 2025-07-16 | Kisunla | $23 |
| Neurocrine BioSciences | Meals · 2025-06-26 | Ingrezza | $18 |
| Pfizer | Meals · 2025-06-17 | Nurtec Odt | $19 |
| Abbvie | Meals · 2025-06-10 | Botox | $26 |
| Abbvie | Meals · 2025-06-10 | Botox | $21 |
| Jazz Pharmaceuticals | Meals · 2025-06-03 | Xywav | $31 |
| Pfizer | Meals · 2025-05-30 | Nurtec Odt | $7 |
| Abbvie | Meals · 2025-05-02 | Qulipta | $28 |
| Abbvie | Meals · 2025-05-01 | Qulipta | $28 |
| Abbvie | Meals · 2025-04-30 | Botox | $31 |
| Abbvie | Meals · 2025-04-24 | Ubrelvy | $20 |
| Abbvie | Meals · 2025-03-18 | Qulipta | $14 |
| Abbvie | Meals · 2025-03-17 | Qulipta | $25 |
| Neurocrine BioSciences | Meals · 2025-03-14 | Ingrezza | $3 |
| Neurocrine BioSciences | Meals · 2025-03-13 | Ingrezza | $20 |
| Neurocrine BioSciences | Meals · 2025-03-13 | Ingrezza | $7 |
| Neurocrine BioSciences | Meals · 2025-03-06 | Ingrezza | $16 |
| Lilly USA | Meals · 2025-03-04 | Kisunla | $17 |
| Jazz Pharmaceuticals | Meals · 2025-03-03 | Xywav | $22 |
| Abbvie | Meals · 2025-02-28 | Qulipta | $29 |
| Abbvie | Meals · 2025-02-27 | Qulipta | $31 |
| Abbvie | Meals · 2025-02-26 | Qulipta | $5 |
| Pfizer | Meals · 2025-02-25 | Nurtec Odt | $20 |
| Genentech USA | Meals · 2025-02-19 | Ocrevus Zunovo | $21 |
| Pfizer | Meals · 2025-02-13 | Nurtec Odt | $3 |
| Abbvie | Meals · 2025-02-04 | Ubrelvy | $27 |
| Abbvie | Meals · 2025-01-28 | Qulipta | $33 |
| Abbvie | Meals · 2025-01-10 | Qulipta | $24 |
| Pfizer | Meals · 2025-01-09 | Nurtec Odt | $5 |
See earlier years (2024, 2021)
2024: $1,107
| Abbvie | Qulipta | $513 | 21 payments
|
| SK Life Science | None | $97 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $71 | 3 payments
|
| Pfizer | Nurtec Odt | $65 | 3 payments
|
| Eisai | Leqembi | $64 | 3 payments
|
| Merz Pharmaceuticals | Xeomin | $56 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $40 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $32 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $27 | 1 payment
|
| Genentech USA | Ocrevus | $26 | 1 payment
|
| Argenx US | Vyvgart | $24 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $24 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $21 | 1 payment
|
| Mitsubishi Tanabe Pharma America | Radicava | $17 | 1 payment
|
| Banner Life Sciences | Bafiertam | $16 | 1 payment
|
| Lilly USA | Emgality | $14 | 1 payment
|
2021: $62
| Novartis Pharmaceuticals | Kesimpta | $23 | 1 payment
|
| Amgen | Aimovig | $23 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
Professional record
- NPI
- 1790147270
- Licence
- CA NP95009672
- Group
- Northbay Physicians Surgery Center, LLC · Northbay Health Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-03-24
- NPI last updated
- 2023-02-06
- NPI record certified
- 2020-09-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1001 Potrero Ave., San Francisco, CA, 94110
This office lists an electronic records connection.